Portal BASE · ID 13691954
Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 2023/304 - Medicamentos do grupo 4: sangue, 2023/481 - Medicamentos diversos, 2023/491 - Medicamentos do foro oncológico e imunomoduladores, 2023/492 - Medicamentos anti-infeciosos, 2024/780 - Medicamentos do aparelho locomotor, usados no tratamento das doenças endócrinas e hormonas, 2024/900 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH, 2024/1077 - Medicamentos diversos (II), 2025/1303 - Medicamentos diversos e 2025/1589 - Medicamentos diversos para aquisição de medicamentos
Buyer
NIF 508741823
- Base price / estimate
- 32,830,391.00 €
- Contractual price
- Not available
- Reported final price
- 1,725.00 €
Values describe contracts, not losses or verified payments. Missing values are not treated as known spending.
Some older records combine contractual and final values. This limitation remains visible until reimport. These are not verified payments.
Main suppliers
Supplier totals use published shares; where unavailable, equal allocation is an estimate.
Contract Details
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
- CPV
- 33600000
- Contract Type
- Aquisição de bens móveis
- Location
- Portugal, Porto, Póvoa de Varzim
- Publication
- 2026-02-26
- Celebration
- 2026-01-29
Data coverage
Source evidence: Portal BASE · Not available
essential fields present: 4 (5)
Missing fields: contractual price
Not available
Risk Flags
An indicator describes a pattern in the data. It does not establish wrongdoing. No indicators does not certify a contract.
A2 · Late Publication
Publication is more than 10 calendar days after signing. This configured delay is not a legal deadline determination.
Source evidence
- Rule
- A2/A3 late publication: 28 days after signing (threshold: 10)
- Publication Date
- 2026-02-26
- Signing Date
- 2026-01-29
- Days Late
- 28
A2_PUBLICATION_AFTER_CELEBRATION · HIGH · 2026-03-06 · Not available
Experimental indicators and advanced analysis
A9 · Abnormal Price Reduction
Reported final price is below half the positive base price. A reduction is descriptive and requires source review.
Source evidence
- Rule
- A9 price reduction: ratio 0.0001 outside [0.5, 1.5]
- Base price
- 32830391.0
- Total effective price
- 1725.0
- Ratio
- 0.0001
A9_PRICE_REDUCTION · LOW · 2026-03-06 · Not available
How it works · Read a public contract